ArticleTranslational oncology2016

Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial: A TITE-CRM Phase I/II Clinical Trial.

Michelle M Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.